Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy

Mauri Kouri (Corresponding Author), Leena Kankaanranta, Tiina Seppälä, Leena Tervo, Merja Rasilainen, Heikki Minn, Olli Eskola, Jyrki Vähätalo, Anders Paetau, Sauli Savolainen, Iiro Auterinen, Juha Jääskeläinen, Heikki Joensuu

    Research output: Contribution to journalArticleScientificpeer-review

    31 Citations (Scopus)

    Abstract

    A large, rapidly progressing, unresectable undifferentiated sinonasal head and neck carcinoma regressed rapidly following single fraction boron neutron capture therapy (BNCT). The main toxicity consisted of mucositis lasting for a few days. The quality of life improved and was excellent until tumour recurrence 6 months after the date of BNCT.
    Original languageEnglish
    Pages (from-to)83 - 85
    Number of pages3
    JournalRadiotherapy and Oncology
    Volume72
    Issue number1
    DOIs
    Publication statusPublished - 2004
    MoE publication typeA1 Journal article-refereed

    Keywords

    • boron neutron capture therapy
    • head and neck carcinoma
    • sinonasal carcinoma
    • boronophenylalanine
    • positron emission tomography

    Fingerprint Dive into the research topics of 'Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy'. Together they form a unique fingerprint.

  • Cite this

    Kouri, M., Kankaanranta, L., Seppälä, T., Tervo, L., Rasilainen, M., Minn, H., Eskola, O., Vähätalo, J., Paetau, A., Savolainen, S., Auterinen, I., Jääskeläinen, J., & Joensuu, H. (2004). Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy. Radiotherapy and Oncology, 72(1), 83 - 85. https://doi.org/10.1016/j.radonc.2004.03.016